These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
916 related articles for article (PubMed ID: 26429879)
21. Targeting osteopontin suppresses glioblastoma stem-like cell character and tumorigenicity in vivo. Lamour V; Henry A; Kroonen J; Nokin MJ; von Marschall Z; Fisher LW; Chau TL; Chariot A; Sanson M; Delattre JY; Turtoi A; Peulen O; Rogister B; Castronovo V; Bellahcène A Int J Cancer; 2015 Sep; 137(5):1047-57. PubMed ID: 25620078 [TBL] [Abstract][Full Text] [Related]
22. CLIC1 regulation of cancer stem cells in glioblastoma. Randhawa K; Jahani-Asl A Curr Top Membr; 2023; 92():99-123. PubMed ID: 38007271 [TBL] [Abstract][Full Text] [Related]
23. Extracellular vesicles from human liver stem cells inhibit renal cancer stem cell-derived tumor growth in vitro and in vivo. Brossa A; Fonsato V; Grange C; Tritta S; Tapparo M; Calvetti R; Cedrino M; Fallo S; Gontero P; Camussi G; Bussolati B Int J Cancer; 2020 Sep; 147(6):1694-1706. PubMed ID: 32064610 [TBL] [Abstract][Full Text] [Related]
24. Bmi1 regulates human glioblastoma stem cells through activation of differential gene networks in CD133+ brain tumor initiating cells. Vora P; Seyfrid M; Venugopal C; Qazi MA; Salim S; Isserlin R; Subapanditha M; O'Farrell E; Mahendram S; Singh M; Bakhshinyan D; Chokshi C; McFarlane N; Dvorkin-Gheva A; Brown KR; Murty N; Moffat J; Bader GD; Singh SK J Neurooncol; 2019 Jul; 143(3):417-428. PubMed ID: 31115870 [TBL] [Abstract][Full Text] [Related]
25. PGE Lin MC; Chen SY; He PL; Herschman H; Li HJ Int J Cancer; 2018 Sep; 143(6):1440-1455. PubMed ID: 29658109 [TBL] [Abstract][Full Text] [Related]
26. Short non-coding RNA sequencing of glioblastoma extracellular vesicles. de Mooij T; Peterson TE; Evans J; McCutcheon B; Parney IF J Neurooncol; 2020 Jan; 146(2):253-263. PubMed ID: 31912278 [TBL] [Abstract][Full Text] [Related]
27. Glioblastoma multiforme-derived extracellular vesicles drive normal astrocytes towards a tumour-enhancing phenotype. Oushy S; Hellwinkel JE; Wang M; Nguyen GJ; Gunaydin D; Harland TA; Anchordoquy TJ; Graner MW Philos Trans R Soc Lond B Biol Sci; 2018 Jan; 373(1737):. PubMed ID: 29158308 [TBL] [Abstract][Full Text] [Related]
28. Tumor-derived extracellular vesicles shuttle c-Myc to promote gastric cancer growth and metastasis via the KCNQ1OT1/miR-556-3p/CLIC1 axis. Li B; Chen Y; Liang L; Wang Y; Huang W; Zhao K; Liu S; Deng G; Chen J Cell Death Dis; 2022 Mar; 13(3):217. PubMed ID: 35260554 [TBL] [Abstract][Full Text] [Related]
29. Shedding of bevacizumab in tumour cells-derived extracellular vesicles as a new therapeutic escape mechanism in glioblastoma. Simon T; Pinioti S; Schellenberger P; Rajeeve V; Wendler F; Cutillas PR; King A; Stebbing J; Giamas G Mol Cancer; 2018 Aug; 17(1):132. PubMed ID: 30165850 [TBL] [Abstract][Full Text] [Related]
30. Exosomal circZNF800 Derived from Glioma Stem-like Cells Regulates Glioblastoma Tumorigenicity via the PIEZO1/Akt Axis. Zhang N; Wu P; Mu M; Niu C; Hu S Mol Neurobiol; 2024 Sep; 61(9):6556-6571. PubMed ID: 38324181 [TBL] [Abstract][Full Text] [Related]
31. Arsenic trioxide disrupts glioma stem cells via promoting PML degradation to inhibit tumor growth. Zhou W; Cheng L; Shi Y; Ke SQ; Huang Z; Fang X; Chu CW; Xie Q; Bian XW; Rich JN; Bao S Oncotarget; 2015 Nov; 6(35):37300-15. PubMed ID: 26510911 [TBL] [Abstract][Full Text] [Related]
32. Histone deacetylase inhibitor ITF2357 (givinostat) reverts transformed phenotype and counteracts stemness in in vitro and in vivo models of human glioblastoma. Marampon F; Leoni F; Mancini A; Pietrantoni I; Codenotti S; Ferella L; Megiorni F; Porro G; Galbiati E; Pozzi P; Mascagni P; Budillon A; Maggio R; Tombolini V; Fanzani A; Gravina GL; Festuccia C J Cancer Res Clin Oncol; 2019 Feb; 145(2):393-409. PubMed ID: 30474756 [TBL] [Abstract][Full Text] [Related]
33. Knockdown of long non-coding RNA XIST exerts tumor-suppressive functions in human glioblastoma stem cells by up-regulating miR-152. Yao Y; Ma J; Xue Y; Wang P; Li Z; Liu J; Chen L; Xi Z; Teng H; Wang Z; Li Z; Liu Y Cancer Lett; 2015 Apr; 359(1):75-86. PubMed ID: 25578780 [TBL] [Abstract][Full Text] [Related]
35. REST-DRD2 mechanism impacts glioblastoma stem cell-mediated tumorigenesis. Marisetty AL; Lu L; Veo BL; Liu B; Coarfa C; Kamal MM; Kassem DH; Irshad K; Lu Y; Gumin J; Henry V; Paulucci-Holthauzen A; Rao G; Baladandayuthapani V; Lang FF; Fuller GN; Majumder S Neuro Oncol; 2019 Jun; 21(6):775-785. PubMed ID: 30953587 [TBL] [Abstract][Full Text] [Related]
36. Breaking through the glioblastoma micro-environment via extracellular vesicles. Simon T; Jackson E; Giamas G Oncogene; 2020 Jun; 39(23):4477-4490. PubMed ID: 32366909 [TBL] [Abstract][Full Text] [Related]
37. Directly visualized glioblastoma-derived extracellular vesicles transfer RNA to microglia/macrophages in the brain. van der Vos KE; Abels ER; Zhang X; Lai C; Carrizosa E; Oakley D; Prabhakar S; Mardini O; Crommentuijn MH; Skog J; Krichevsky AM; Stemmer-Rachamimov A; Mempel TR; El Khoury J; Hickman SE; Breakefield XO Neuro Oncol; 2016 Jan; 18(1):58-69. PubMed ID: 26433199 [TBL] [Abstract][Full Text] [Related]
38. Targeting cancer stem cells in glioblastoma multiforme using mTOR inhibitors and the differentiating agent all-trans retinoic acid. Friedman MD; Jeevan DS; Tobias M; Murali R; Jhanwar-Uniyal M Oncol Rep; 2013 Oct; 30(4):1645-50. PubMed ID: 23877261 [TBL] [Abstract][Full Text] [Related]
39. Inhibition of tumor progression and M2 microglial polarization by extracellular vesicle-mediated microRNA-124 in a 3D microfluidic glioblastoma microenvironment. Hong S; You JY; Paek K; Park J; Kang SJ; Han EH; Choi N; Chung S; Rhee WJ; Kim JA Theranostics; 2021; 11(19):9687-9704. PubMed ID: 34646393 [No Abstract] [Full Text] [Related]
40. Metformin repositioning as antitumoral agent: selective antiproliferative effects in human glioblastoma stem cells, via inhibition of CLIC1-mediated ion current. Gritti M; Würth R; Angelini M; Barbieri F; Peretti M; Pizzi E; Pattarozzi A; Carra E; Sirito R; Daga A; Curmi PM; Mazzanti M; Florio T Oncotarget; 2014 Nov; 5(22):11252-68. PubMed ID: 25361004 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]